Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42e94091a4fc81b8d0237117707cc7ee |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
filingDate |
2004-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2011-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4030dfb6b6582b7f4541b4400cf10079 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fafdc197e7ea8f5f02dd266b389772d2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a41d174d131b2406b1d3bded8f4d9295 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed7ad7e3787c050530020845df895731 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba6dd73d289382978b01252e3f70b21e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02c9e6258bdb8d18ad8457b3bc1e2532 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8e2c0f4ece34f59d4308c61aa3bdad3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50e070c301ef7469dbb2b78b2681f878 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b7a0a71051408abc1d30c5c54348927 |
publicationDate |
2011-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2004312413-C1 |
titleOfInvention |
Pyrrolotriazine compounds as kinase inhibitors |
priorityDate |
2003-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |